reports
Storebrand ASA: 1 director
A director at Storebrand ASA maiden bought 10,000 shares at 106.500NOK and the significance rating of the trade was 59/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...
Loulis Food Ingredients SA: 1 director
A director at Loulis Food Ingredients SA bought 31,451 shares at 2.740EUR and the significance rating of the trade was 59/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two y...
Eduspec Holdings Berhad: 1 director
A director at Eduspec Holdings Berhad bought 13,200,000 shares at 0.150MYR and the significance rating of the trade was 62/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ...
Silver Ridge Holdings Bhd: 3 directors
Three Directors at Silver Ridge Holdings Bhd sold/bought 1,191,600 shares at between 0.325MYR and 0.380MYR. The significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's...
Amarin Corporations Public Company Ltd: 1 director
A director at Amarin Corporations Public Company Ltd bought 3,880,619 shares at 5.000THB and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over...
Long An Book And Educational Equipment Jsc: 1 director
A director at Long An Book And Educational Equipment Jsc sold 532,400 shares at 0.000VND and the significance rating of the trade was 92/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over...
Essity Aktiebolag (publ): 2 directors
A director at Essity Aktiebolag (publ) maiden bought 729 shares at 263.747SEK and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last t...
- Thomas J. Schiessle
New CEO from 01.07.24 - "Priority Reset", Action Plan 2025 to be revis...
Evotec is facing a "priority reset", as Supervisor Board Chair Dr Iris Löw-Friedrich emphasised on 24.04.24. In FY 23, the cyber-attack in Q2/23 was compounded by a noticeable decline in demand in Q4/23, which exposed the weakness of the very broad growth strategy. The "performance review" initiated in Q4/23 aims to return to profitable growth.
- ABGSC Renewable Energy Research
- Åsne Holsen
- Daniel Vårdal Haugland
- ABGSC Capital Goods Research
- Anders Idborg
- Karl Bokvist
- Olof Cederholm
Maisons du Monde : Filing of the 2023 Universal Registration Document
Maisons du Monde : Filing of the 2023 Universal Registration Document PRESS RELEASENantes, 26 April 2024 Regulated InformationFiling of the 2023 Universal Registration Document Maisons du Monde announces the release of its 2023 Universal Registration Document. The 2023 Universal Registration Document was filed with the Autorité des Marchés Financiers (AMF) on 25 April 2024 in ESEF format, under number D.24-0332. This 2023 Universal Registration Document (fiscal year ended on December 31, 2023) includes among other items: - the annual financial report,- the report prepared by t...
Maisons du Monde : Mise à disposition du Document d’Enregistrement Uni...
Maisons du Monde : Mise à disposition du Document d’Enregistrement Universel 2023 COMMUNIQUE DE PRESSENantes, le 26 avril 2024 Mise à disposition du Document d’Enregistrement Universel 2023 Maisons du Monde annonce la publication de son Document d’Enregistrement Universel 2023. Le Document d’Enregistrement Universel 2023 a été déposé auprès de l’Autorité des Marchés Financiers (AMF) le 25 avril 2024 sous le n°D.24-0332. Le Document d’Enregistrement Universel, établi pour l’exercice clos le 31 décembre 2023,inclut notamment :- le rapport financier annuel,- le rapport du Conseil d’adminis...
Communiqué de mise à disposition du Rapport sur le Gouvernement d’Entr...
Communiqué de mise à disposition du Rapport sur le Gouvernement d’Entreprise relatif à l’exercice 2023 Communiqué de mise à disposition duRapport sur le Gouvernement d’Entreprise relatif à l’exercice 2023 La société annonce avoir mis à disposition du public et déposé auprès de l’Autorité des Marchés Financiers son Rapport sur le Gouvernement d’Entreprise relatif à l’exercice 2023. Le Rapport sur le Gouvernement d’Entreprise peut être consulté sur le site internet de la société à l’adresse -fromagedairy.com, dans la rubrique « information réglementée ». Viroflay, le 26 avril 2024 P...
Tevogen Bio CEO Highlights Expected Reporting of a $94.9 Million Liabi...
Tevogen Bio CEO Highlights Expected Reporting of a $94.9 Million Liability Elimination, AI Initiative, and Leadership Appointments Conversion of promissory notes into common stock removed $94.9 million in pro forma balance sheet liabilities.The converted common stock is included in the company’s total 165 million outstanding shares.The Tevogen.ai initiative aims to harness the immense potential of AI to enhance drug discovery, development, manufacturing, distribution, and patient access. WARREN, N.J., April 26, 2024 (GLOBE NEWSWIRE) -- (“Tevogen” or “Tevogen Bio”) (Nasdaq: ) is a clin...
- Jayanth Kandalam
Ardagh - Earnings Flash - Q1 FY 2024 Results - Lucror Analytics
Ardagh Group has released very weak Q1/24 numbers, with adverse results from the Glass Packaging business only partly offset by demonstrable strength in Ardagh Metals Beverage Packaging. While management has reiterated its full-year guidance, this will likely have a negligible impact on overall credit metrics. Ardagh's debt levels, particularly in the Glass Packaging restricted group, are unsustainable. While the Apollo deal allows for the timely repayment of the 2025 maturities, there are signi...
Press Release on April 26, 2024, Relating to the Filing of the Draft R...
Press Release on April 26, 2024, Relating to the Filing of the Draft Response Document Prepared by BELIEVE in response to the simplified offer on the shares of Believe This document is an unofficial English-language translation of the press release relating to the filing of the draft response document (projet de note en réponse) which was filed with the French Autorité des marchés financiers on April 26, 2024, and which remains subject to its review. In the event of any discrepancies between this unofficial English-language translation and the official French press release, the official Fr...
COMMUNIQUÉ DU 26 AVRIL RELATIF AU DÉPÔT DU PROJET DE NOTE ÉTABLI PAR L...
COMMUNIQUÉ DU 26 AVRIL RELATIF AU DÉPÔT DU PROJET DE NOTE ÉTABLI PAR LA SOCIÉTÉ BELIEVE EN RÉPONSE À L’OFFRE PUBLIQUE D’ACHAT SIMPLIFIÉE VISANT LES ACTIONS DE LA SOCIÉTÉ BELIEVE INITIÉE PAR UPBEAT BIDCO COMMUNIQUÉ DU 26 AVRIL RELATIF AU DÉPÔT DU PROJET DE NOTE ÉTABLI PAR LA SOCIÉTÉ EN RÉPONSE À L’OFFRE PUBLIQUE D’ACHAT SIMPLIFIÉE VISANT LES ACTIONS DE LA SOCIÉTÉ BELIEVE INITIÉE PAR UPBEAT BIDCO Le présent communiqué a été établi par Believe et diffusé conformément aux dispositions de l’article 231-26 du règlement général de l’Autorité des marchés financiers (l’ « A...
ONWARD® Medical annonce ses résultats financiers et opérationnels pour...
ONWARD® Medical annonce ses résultats financiers et opérationnels pour l’exercice 2023 et partage les faits qui ont marqué l’exercice 2024 à ce jour Dépôt auprès de la FDA d’une demande de classification du dispositif ARC-EX® System basée sur les risques (demande « De Novo ») Levée de fonds de 20 millions d’euros Annonce des résultats préliminaires positifs de l’étude pivot Up-LIFT Mise en place d’un partenariat visant à accéder rapidement à la Veterans Health Administration des États-Unis Poursuite de la mise au point de thérapies avec interface cerveau-ordinateur pour les lésions médu...
Nuwellis Announces Pricing of $2.7 Million Public Offering
Nuwellis Announces Pricing of $2.7 Million Public Offering MINNEAPOLIS, April 26, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) (“Nuwellis” or the “Company”), a medical technology company focused on transforming the lives of people with fluid overload, today announced the pricing of a public offering of 11,250,000 shares of its common stock (or pre-funded warrants in lieu thereof) and warrants to purchase up to an aggregate of 16,875,000 shares of its common stock at a combined public offering price $0.24 per share (or pre-funded warrant in lieu thereof) and associated warrant. E...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.